Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04239014
Title A Study to Evaluate the Effectiveness and Tolerability of a Second Maintenance Treatment in Participants With Ovarian Cancer, Who Have Previously Received Polyadenosine 5'Diphosphoribose [Poly (ADP Ribose)] Polymerase Inhibitor (PARPi) Treatment. (DUETTE)
Recruitment Withdrawn
Gender female
Phase Phase II
Variant Requirements No
Sponsors AstraZeneca

ovary epithelial cancer

peritoneum cancer

fallopian tube cancer



AZD6738 + Olaparib

Age Groups: adult | senior
Covered Countries USA | CAN

No variant requirements are available.